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Abstract: Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide. It is a potentially preventable disease and ideally suited to a screening program. CRC screening is an early detection strategy for occupational health nurses to offer in the workplace. Education and outreach are key components of this intervention. Many test options are available for CRC screening. This article is an integrative literature review that summarizes evidence to support colorectal screening in the workplace, offers screening recommendations from authoritative agencies, and provides guidance for occupational health nurses who plan to implement a screening program. Current screening limitations using fecal occult blood tests are addressed and an inventory of CRC screening activities in select countries is included.
Keywords: colorectal cancer, fecal occult blood test, screening P romotion of employee health and well-being is a core element of occupational health nursing practice. Workplace cancer screening programs can increase awareness of cancer and educate employees about managing risk factors and identifying symptoms. Programs can operate at a number of levels from awareness and knowledge-based campaigns via dedicated seminars, websites, posters, and brochures to cancer screening programs. This article provides occupational health nurses with knowledge about the benefits and effective use of colorectal cancer (CRC) screening in the workplace. The article discusses CRC screening methods and reviews existing studies on CRC screening in the workplace.
Incidence and Mortality
CRC is an all too common and lethal disease worldwide. CRC refers to cancer of the large intestine or bowel (e.g., colon and rectum; American Cancer Society, 2014). According to the World Health Organization's (WHO) International Agency on Research for Cancer (IARC), CRC is the third most commonly diagnosed cancer worldwide (1.4 million cases, 9.7%) and the fourth most common cause of cancer deaths worldwide (Ferlay et al., 2012) . Globally, CRC is the third most common cancer among men and the second most common cancer among women (Jemal et al., 2011) . According to the American Cancer Society, CRC is expected to be one of the top three cancers to occur in men and women in the United States in 2015 (Siegel, Miller, & Jemal, 2015) . The highest incidence rates are in North America, Australia, New Zealand, Europe, and Japan (American Cancer Society, 2011).
In contrast to incidence trends, decreasing CRC mortality rates have been observed in several countries worldwide and are most likely attributed to CRC screening and improved treatment. However, increasing mortality rates are still occurring in countries that have insufficient health infrastructure and resources including Mexico, Brazil, Romania, and Russia (Center, Jemal, Smith, & Ward, 2009 ).
Causes and Risk Factors
The exact cause of CRC is unknown, but several factors are understood to increase the risk of developing the disease (National Cancer Institute, 2014) . A leading risk factor is age. In developed countries, more than 90% of cases are diagnosed in individuals aged 50 or older (American Cancer Society, 2011) . Risk of developing CRC is influenced by both lifestyle and genetic factors. Established and suspected modifiable risk factors for CRC include obesity, physical inactivity, smoking, heavy alcohol consumption, a diet high in red or processed meats, and inadequate consumption of fruits and vegetables (Ferguson, 2010) . Other risk factors include family history of CRC and personal history of inflammatory bowel disease (e.g., ulcerative colitis or Crohn's disease; American Cancer Society, 2014).
Aside from genetic predisposition and dietary habits, more recent evidence has shown that environmental and occupational risk factors are associated with CRC (Oddone, Modonesi, & Gatta, 2014) . A study examining the relationship between CRC and occupational exposure, revealed higher risks of CRC among workers exposed to chemical compounds for processing leather, basic metal fabrication, plastic and rubber manufacturing, and asbestos exposures (Oddone et al., 2014) . Studies have linked firefighting with increased risk of cancer due to occupational exposure to several carcinogens. A study by the National Institute for Occupational Safety and Health (NIOSH) of approximately 30,000 U.S. firefighters from 1950 to 2009 found that firefighters are at higher risk of cancer of the respiratory, digestive, and urinary systems compared with the general population. In a study of Philadelphia firefighters, researchers observed increased CRC mortality (Baris et al., 2001) . If an increased CRC risk is associated with certain occupations, it would be appropriate to introduce screening strategies accordingly.
Screening Methods
CRC can be treated successfully if detected early. When CRC is detected at an early stage, the 5-year survival rate increases to 90%; however, only 39% of CRCs are diagnosed at this stage, mainly due to underuse of screening techniques (American Cancer Society, 2011). The current recommendation for CRC screening in most countries is to begin screening at age 50 for individuals who are at average risk of developing CRC. Individuals at higher risk of CRC should begin screening at a younger age and may need to be tested more frequently (American Cancer Society, 2011) . Screening methods for CRC include fecal occult blood test (FOBT), flexible sigmoidoscopy, and colonoscopy.
Colonoscopy
The long-term effect of colonoscopy on mortality from CRC has shown that the endoscopic removal of adenomas can reduce mortality (Zauber et al., 2012) . However, colonoscopy requires a skilled examiner, is expensive, is invasive, is not convenient but is time-consuming, requires full bowel preparation, and has more risks for workers (Winawer, 2007) . As a result, colonoscopy is not a feasible screening tool in many low-resource countries (Center et al., 2009 ).
Flexible Sigmoidoscopy
Randomized controlled trials (RCTs) have shown a reduction in CRC incidence and mortality from screening with flexible sigmoidoscopy (Atkin et al., 2010) . Similar to the preparation for colonoscopy, preparation for a sigmoidoscopy may also require special diet, laxatives, or enemas to clean the colon. However, sigmoidoscopy is generally not as invasive as colonoscopy and usually easier to tolerate than the preparation for a colonoscopy. Most individuals do not need sedation for a sigmoidoscopy (Holme, 2014) . The procedure examines the left colon, the site of 75% of all CRC. However, the right colon is not examined during a sigmoidoscopy (Georgios & Bampali, 2013) .
FOBT
CRC may shed blood and other tissue components that can be detected in the feces long before the development of clinical symptoms. Therefore, stool analyses using FOBT can allow early detection of cancer for CRC in individuals without symptoms (World Gastroenterology Organization/International Digestive Cancer Alliance, 2007) . FOBT is inexpensive, easy to perform, and a practical screening option in many countries around the world (Center et al., 2009 ).
Types of FOBT
Currently two types of FOBT are available commercially. The immunochemical FOBT (iFOBT or FIT [fecal immunochemical test]) has a higher sensitivity and specificity analytically and clinically than the guaiac-based FOBTs (gFOBTs; Whitlock, Lin, Liles, Beil, & Fu, 2008) . The use of annual high-sensitivity FOBT (sensitivity for cancer ≥70%) with a false-positive rate less than 10% (specificity >90%), is estimated to require the fewest colonoscopies while achieving a gain in life-years similar to screening colonoscopies every 10 years (U.S. Preventive Services Task gFOBT. The gFOBT is a commonly used method for detecting blood in feces. Screening with gFOBT has been shown to be effective in reducing CRC mortality (Hewitson, Glasziou, Irwig, Towler, & Watson, 2007) . RCT results of screening with gFOBT found that biennial gFOBT can reduce CRC mortality by 16% after 12 to 18 years of screening and by 25% for individuals who had partaken in gFOBT screening once in their lifetimes (Rex et al., 2009 ). The gFOBTs come in two forms, the conventional form with lesser sensitivity and a more sensitive version. The conventional gFOBTs typically have an analytical sensitivity (limit of detection) of between 0.3 and 1 mg Hb/g of feces; however, sensitivity is affected by the sample loading levels and the time between collection and testing. The gFOBT is more sensitive (0.15 mg Hb/g) if the sample is hydrated on the test kit prior to adding hydrogen peroxide. This method is currently used in the Hemoccult Sensa, Beckman Coulter Inc., Fullerton, California, United States (Segnan, Patnick, & Von Karsa, 2010) .
iFOBT or FIT. A review of RCT comparing diagnostic accuracy of the gFOBT versus iFOBT found that iFOBT is superior to gFOBT with respect to detection rate and positive predictive value for adenomas and cancer (van Rossum et al., 2008) . One RCT reported the FIT to be twice as likely to find CRC and five times more likely to find advanced polyps (Levin et al., 2008) .
Given the lack of additional evidence, the interval for iFOBT screening can best be set similar to gFOBT, not to exceed 2 years. The analytical superiority of iFOBT demonstrates that it has become the test of choice for CRC screening programs (Segnan et al., 2010) . Immunochemical tests confer higher analytical specificity for human hemoglobin; more sensitive detection systems increase test sensitivity in low blood concentrations (Leddin et al., 2010; Segnan et al., 2010) .
CRC Screening in the Workplace
In a study of the Toronto Police Service that evaluated a workplace CRC awareness program, researchers discovered various methods (e.g., viewing a video on CRC screening, receiving a FOBT kit in the mail, and receiving educational materials and reminders in the mail) that were moderately effective in increasing CRC awareness and screening rates in the workplace (Bagai et al., 2007) . Advantages of CRC screening in the workplace include better employee health, increased productivity, and a convenient location for screening and education (Bagai et al., 2007) .
A study to evaluate the impact of a workplace intervention program using FIT kits and surveys demonstrated an increase in CRC screening rates in firefighters (Walsh, Potter, Arora, Gildegorin, & Terdiman, 2014) . Although offering workplace CRC screening can be challenging (e.g., identifying those workers eligible for screening, reaching individuals, and ensuring that abnormal results are communicated to workers), several strategies to address these challenges include questionnaires to determine eligibility, a telephonic or electronic communication plan, abnormal test monitoring, and annual screening opportunities (Walsh et al., 2014) .
Shared Decision Making (SDM)
Today, health care decisions are subject to patient preferences, values, and culture (Christy & Rawl, 2013) . SDM is often part of screening (Christy & Rawl, 2013) . In the context of CRC screening, the worker and clinician share information about "CRC screening and risk factors, discussion of pros and cons associated with screening, and collaboration in decisionmaking" (Christy & Rawl, 2013, p. 313) . More specifically, the SDM process specifies that individuals should (a) be informed of their risk of developing CRC and the seriousness of CRC; (b) understand the risks, benefits, alternatives, and uncertainties of the various CRC screening tests; (c) weigh their values regarding the potential benefits and harms associated with CRC screening; and (d) engage in decision making about CRC screening at a level at which they desire and feel comfortable (Christy & Rawl, 2013) . Christy and Rawl (2013) identified individuals who used SDM at their desired level and found they were more likely to be screened; individuals who felt that their providers had communicated effectively and educated them about their health care were more likely to complete the FOBT screening test as well. Occupational health nurses should use SDM when informing employees about CRC screening at the workplace to create a positive worker-provider relationship, increasing employee knowledge and workers' desire to seek CRC screening. Table 1 offers an inventory of CRC screening activities in select countries around the world. The inventory demonstrates that screening options using gFOBT and iFOBT are widely available. Some countries have implemented national screening programs using FOBT, including Germany, Japan, Ireland and the United Kingdom. However, CRC screening initiatives are scarce in Africa, Asia, and South America.
FOBT Screening Programs

Literature Review of FOBT
As can be seen in Table 2 , international studies and many global authoritative agencies support the use of FOBT for CRC screening. For example, the USPSTF (2008) recommends screening for CRC using FOBT, sigmoidoscopy, or colonoscopy in adults aged 50 to 75 years. Only the FOBT for adults aged 50 to 74 years has been recommended to date by the Council of the European Union for CRC screening (Segnan et al., 2010) . The American Cancer Society recommends using highly sensitive versions of gFOBT or FIT annually.
FOBT has been shown in several randomized studies to reduce CRC mortality by 15% to 33% in cohorts and 45% by compliers, depending on the type of slide and frequency of testing (World Gastroenterology Organization/International Digestive Cancer Alliance, 2007). In addition, screening for CRC using FOBT can detect CRC at an earlier stage than symptomatic presentation, and has the potential to significantly decrease CRC mortality (Hewitson et al., 2007) .
Laboratory Accreditation and Quality Monitoring Recommendations
CRC screening services should be associated with a laboratory accredited to ISO 15189:2007 Medical Laboratories, which have met particular requirements for quality and competence. The laboratories should adhere to Internal Quality Control (IQC) procedures and participate in an appropriate External Quality Assessment Scheme (EQAS; Segnan et al., 2010) .
All laboratories providing population screening should be led by a qualified clinical chemist trained and experienced in the required analysis techniques using clinical quality assurance procedures (Segnan et al., 2010) .
Test Interferences Dietary Restriction
Dietary constituents can potentially interfere with gFOBT tests; interference is significantly less for immunochemical tests (Segnan et al., 2010) . Dietary restrictions before screening have been required for clinical tests in the past. However, dietary restrictions are no longer recommended due to limited clinical significance and possible negative impact on screening adherence (Segnan et al., 2010) .
Drug Restriction
Although contraindications were found in the literature regarding the effect of anticoagulants on screening, drug restrictions are not recommended for screening programs using either guaiac-based or immunochemical tests (Segnan et al., 2010) .
Educational Materials
Occupational health nurses can offer educational materials to their employees to support and promote FOBT screening in the workplace. Suggested organizations to retrieve educational 
Germany
Yes National screening program offers free colonoscopy in addition to gFOBT. Individual's aged 50 to 54 years use yearly gFOBT. For 55 and older, there is a choice, either two colonoscopies (second colonoscopy minimum 10 years after the first; every screening colonoscopy performed after age 65 counts as a second colonoscopy) or biennial gFOBT. An information sheet, which explains the potential benefits and harms of both screening methods, is given to patients. Source: National Cancer Institute (2008).
Indonesia
No No national CRC screening program in Indonesia. The gFOBT may be available in some regions. Source: Sudoyo et al. (2014) .
Ireland
Yes National CRC Program offers free colon screening to men and women aged 60 to 69 years using FIT every 2 years. The program will be expanded over time until the full 55 to 74 age group is reached. Source: National Cancer Screening Service, Ireland (2012).
Japan
Yes National CRC screening program using annual iFOBT was implemented in 1992. The program is conducted through local governments and targets 35 million individuals aged 40 and older who are national insurance holders. National CRC screening guidelines were revised in 2005 to recommend FOBT or iFOBT for organized screening, although iFOBT is stated as being the preferred test. Increasing the participation rate (18%) is an important goal. Source: National Cancer Institute (2008). 
Summary
Mortality from CRC is preventable with early screening and detection. Although many countries have national guidelines for CRC screening (i.e., FOBT for individuals older than 50; those with abnormal results are offered colonoscopies), these programs are infrequently implemented. Screening tests largely depend on individual worker and population factors, and limitations imposed by health resources and financial restrictions in each country. To ensure individuals receive timely and optimal CRC screening and care, occupational health nurses can promote widespread awareness and screening for CRC at the workplace. Individuals should be educated on CRC, undergo preventive screening, and seek health care at the first sign of symptoms.
International studies support screening for CRC using FOBT. It is simple, safe, and less expensive. To ensure effectiveness of FOBT screening, research indicates that the screening intervals should not exceed 2 years. In comparison with the gFOBT, the iFOBT has higher sensitivity, specificity, and test adherence 
Netherlands
Phased basis Prior to a decision on a national screening program for bowel cancer screening, several trials have taken place. As of September 2013, a national screening program is being introduced gradually; the Health Council Committee believes that new research should preferably be carried out within this national program. However, an exception maybe in order if that is not possible. In this study, 22,000 men and women between 50 and 75 years of age are biennially screened for colon cancer. The selected test method is the iFOBT. Source: National Cancer Institute (2008).
Sweden
No Population-based service screening for CRC was introduced in Stockholm county in January 2008. This is the first county in Sweden to initiate a CRC service screening program. The program uses FOBT and targets the age group 60 to 69 years, men and women, at 2 years interval. Participants with positive test results are referred for colonoscopy. Source: National Cancer Institute (2008).
United Kingdom Yes
In England, men and women are offered free CRC using the gFOBT every 2 years from ages 60 to 69 years. The English program is gradually being extended to also invite men and women aged 70 to 74 years. In Northern Ireland, men and women are offered CRC every 2 years from ages 60 to 71 years. In Scotland, men and women are offered the test every 2 years from ages 50 to 74 years. And in Wales, men and women are offered screening every 2 years from ages 60 to 74 years. Source: National Cancer Institute (2008).
United States
No No organized national program, although a demonstration pilot project targeting low-income, uninsured individuals has been implemented in some areas. Some organized programs operate through health plans and local health departments. Screening options using gFOBT and iFOBT is widely available, including sigmoidoscopy, colonoscopy, and double-contrast barium enema. Source: National Cancer Institute (2008).
Note. CRC = colorectal cancer; iFOBT = immunochemical fecal occult blood test; gFOBT = guaiac-based fecal occult blood tests; FIT = fecal immunochemical test. China Overall, IFOBT with twosample testing showed compatible sensitivity and specificity to the threesample testing, and had a lower relative cost per cancer detected than the three-sample testing.
In conclusion, the new Hemosure IFOBT with two consecutive stool samples appears to be the most cost-effective approach for colon cancer screening.
van Rossum et al.
One randomized controlled trial compared the guaiac FOBT with FIT over one round, with the FIT set at an analytical sensitivity that gave a positivity rate approximately twice that of the guaiac test. This study demonstrated that participation and detection rates for advanced adenomas and cancer were significantly higher for FIT compared with guaiac FOBT.
Adults aged >50 years Netherlands
The guaiac FOBT test is not specific for blood, which creates a problem with sensitivity and specificity.
Note. CRC = colorectal cancer; FOBT = fecal occult blood test; FIT = fecal immunochemical test; CDC = Centers for Disease Control and Prevention; USPSTF = U.S. Preventive Services Task Force; RCT = randomized controlled trial; CT = computed tomography; gFOBT = guaiacbased fecal occult blood tests; iFOBT = immunochemical fecal occult blood test. 
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